Oklahoma Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Business Journal.

Press releases published on April 22, 2026

Apr. 22, 2026

Clearfield Sets Fiscal Second Quarter 2026 Earnings Call for Wednesday, May 6, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

Indeterminate GlobeNewswire

Apr. 22, 2026

GROCERY OUTLET INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Grocery Outlet Holding Corp. (NASDAQ:GO) Investors that a Class Action Lawsuit Has Been Filed and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

SIMPLY GOOD FOODS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Simply Good Foods Company on Behalf of Simply Good Foods Stockholders and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

ONEMAIN INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating OneMain Holdings, Inc. on Behalf of OneMain Stockholders and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

VERITONE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Veritone, Inc. on Behalf of Veritone Stockholders and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

ROSEN, LEADING INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DRVN

Indeterminate GlobeNewswire

Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

Indeterminate GlobeNewswire

Apr. 22, 2026

 nCino Announces Nick Edwards as Managing Director for APAC

Indeterminate GlobeNewswire

Apr. 22, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Indeterminate GlobeNewswire

Apr. 22, 2026

TransUnion Applauds FHFA, HUD for Advancing VantageScore in Mortgage Lending

Indeterminate GlobeNewswire

Apr. 22, 2026

New Findings Point to a Proven Path Forward for California’s Permanent Supportive Housing

Indeterminate GlobeNewswire

Apr. 22, 2026

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

AI GPU Rental Launches New AI-Driven Supercomputing to Simplify Bitcoin Passive Earnings

Indeterminate GlobeNewswire

Apr. 22, 2026

Hammond Power Solutions Announces First Quarter 2026 Financial Results Conference Call and Webcast Notification

Indeterminate GlobeNewswire

Apr. 22, 2026

UNCF Mourns the Passing of Congressman David Scott

Indeterminate GlobeNewswire

Apr. 22, 2026

Home BancShares, Inc. Announces Second Quarter Dividend

Indeterminate GlobeNewswire

Apr. 22, 2026

Canfor releases 2025 Sustainability Report

Indeterminate GlobeNewswire

Apr. 22, 2026

Blue Jay Gold Corp. Appoints Colin Healey to Board Of Directors

Indeterminate GlobeNewswire